Artivion, Inc.
Artivion, Inc. (AORT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · AORT · as of Jun 9, 2026
Key Statistics
Explore Artivion, Inc. Data
aort stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 12 · Buy rate: 83.3%
The AORT analyst consensus is Buy, based on ratings from 12 Wall Street analysts over the past 3 months. The average 12-month price target is $48.00, representing +135.41% upside from the current price of $20.39.
Competitors & Peers
aort competitorsAORT
ADUS
ARDT
BKD
COGT
INSPStock Performance
Full HistoryAbout Artivion, Inc.
Artivion, Inc. Artivion Inc. is a global company that develops, produces, and supplies medical devices and implantable human tissues. Its product range includes BioGlue, a polymer derived from bovine blood protein c…
what is artivion, inc. · aort stock overview · artivion, inc. company profile · who is artivion, inc. ceo · aort NYSE · artivion, inc. headquarters · artivion, inc. business segments
About Stock Overview & Key Data
Artivion, Inc. (AORT) is a Healthcare company in the Medical - Devices industry, listed on NYSE since Feb 12, 1993. As of the latest trading session, AORT stock price is $20.39, with a market capitalization of $989.8M. The stock has returned -31.07% over the past 12 months and -55.89% year-to-date.
According to 12 Wall Street analysts, the consensus rating for Artivion, Inc. stock is Buy, with an average 12-month price target of $48.00. In fiscal year 2025, Artivion, Inc. reported revenue of $441.3M and net income of $9.8M. For detailed data — including Artivion, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Artivion, Inc. (AORT) stock price is $20.39. The stock is traded on NYSE under the ticker symbol AORT. The 52-week range is $19.16 – $48.25.